Current status of umbilical cord blood hematopoietic stem cell transplantation.
about
Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks.Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.High sensitivity of megakaryocytic progenitor cells contained in placental/umbilical cord blood to the stresses during cryopreservation.Fibroblast growth factor and ex vivo expansion of hematopoietic progenitor cells.The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis.Optimizing donor selection in a cord blood bank.Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank.Viability and functional capacity after thawing of hematopoietic progenitor cells cryopreserved at a cord blood stem cell bank in Colombia.Cord Blood Banking and Transplantation in China: A Ten Years Experience of a Single Public Bank.Pre-birth selection of umbilical cord blood donorsIL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells.Age and stage dependency of estrogen receptor expression by lymphocyte precursors.Strategies to enhance umbilical cord blood stem cell engraftment in adult patients.Hematopoietic stem cells in neonates: any differences between very preterm and term neonates?Results of unrelated umbilical cord blood hematopoietic stem cell transplantation.Stem cells for obstetricians and gynecologists.Knowledge and attitudes of pregnant women with regard to collection, testing and banking of cord blood stem cells.Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood.Clinical and experimental uses of umbilical cord blood.Clinical application of hematopoietic progenitor cell expansion: current status and future prospects.HLA-identical stem cell transplantation: is there an optimal CD34 cell dose?Recent advances in the treatment of infant acute myeloid leukemia.Using a technological community framework to manage new medical technologies. The case of umbilical cord blood (UCB) banking.Leukemia cells and the cytokine network: therapeutic prospects.Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results.On how Rac controls hematopoietic stem cell activity.Induction of melanocytes from embryonic stem cells and their therapeutic potential.Development of new method and protocol for cryopreservation related to embryo and oocytes freezing in terms of fertilization rate: A comparative study including review of literature.What is the future for cord blood stem cells?Cord blood transplantation in adults.Evaluation of ABX Pentra DX 120 and Sysmex XE-2100 in umbilical cord blood.The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs.Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.Hematopoietic stem cells: multiparameter regulation.Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.Factor predicting total nucleated cell counts in cord blood units.Mouse mesenchymal stem cells can support human hematopoiesis both in vitro and in vivo: the crucial role of neural cell adhesion molecule.Does the time between collecting and processing umbilical cord blood samples affect the quality of the sample?Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.Multipotent neural precursors express neural and hematopoietic factors, and enhance ex vivo expansion of cord blood CD34+ cells, colony forming units and NOD/SCID-repopulating cells in contact and noncontact cultures.
P2860
Q31048572-2E29B9F8-3827-4860-A5E9-F036B1E0B1C2Q33340497-FE36309A-5826-4E07-80ED-F70AE2703109Q33361807-53A019C1-9763-47E8-AE36-358634CF74ADQ33364322-BE1D150E-618F-4F9B-990F-1CB9F8ECC19DQ33445489-01DC297A-2E32-44B1-B149-688B88A5D620Q33448051-596CB853-9FA9-4055-A464-097B84778865Q33449843-B115A807-1326-4655-95CF-278F3CF068E5Q33452165-67BD0E4F-BA9E-4728-85BE-711DDF8AE0F2Q33455005-C137C613-DD97-48AD-8551-37CFD3DE2F17Q33603132-C431F9CB-7CDE-4703-9A8B-86F0A76125F6Q33930706-ED8EE250-89FA-4322-AA77-7C8728393EE4Q33952968-36AA9B5B-5962-41F6-89E8-E5D6F517216EQ34111059-074EA355-097F-4D3B-BECC-DE6A115CD0AFQ34122675-1B629374-6687-4FBD-A73F-7F879424AC5BQ34326722-EA80590E-38D6-467C-BDD9-31EC496A7F33Q34655280-D43619C6-1BD2-4BA2-99DA-E637B6CE540EQ34994930-8A784491-024A-436C-B0B0-46503E7CB586Q35033764-AE60B21D-1B3C-4372-88C6-5BBF6CC20065Q35038926-D2D6B192-BA4F-4A6C-A590-BE72E74D8A0CQ35079588-C86237A6-1145-4085-993D-47CB4149EA6AQ35128241-3AEF3CBA-F0C1-4247-8302-194058140601Q35152603-5B6CEDB1-E1F3-4D09-8690-EF4990CD8A5DQ35632661-EEAE7B59-B785-4E32-826F-FF1012D70AC9Q35634259-7D501E8D-F867-4FC1-A7FE-E0466A016F58Q35674530-272F853A-6753-4564-8C80-3F61624AF576Q35841708-5D9A8DAB-C522-41B3-9E2F-984BAC65FB8BQ36530307-3CC6D036-64FF-4CEA-8BBF-DB192CF0BF84Q37135048-747CEDAF-9C1E-443D-8C77-8B5378A1F57DQ37323522-D31F7C25-12B9-4A1A-8CF9-E9A77417E515Q37607986-6A878893-AA29-4521-9D94-7D4F31FC10E8Q38449766-957AD3D8-3EF7-444F-A4D0-D2975C7ED442Q38453666-34BDBF34-F5C9-43FA-95CC-53B06C90915CQ38511921-11CFA7C8-D930-407F-A790-3588240D94E6Q38736183-8F9CB676-5C98-443D-A51F-00F429F5C47AQ39010662-77B6B8EC-602E-419A-A5F3-2FB9DA5EAE55Q39627998-E71DFD87-21F1-4553-BC89-B4A927893D1FQ39762414-16D474F3-A7B8-495F-B0D0-CC85F97EF8DAQ40114197-EFF60AE5-8220-44B0-8B9D-D76C1F034E4BQ40416657-73757CC2-1A9C-46A8-B217-FE8D00134739Q40501532-D8411C31-BB00-4F35-B363-747836E8425D
P2860
Current status of umbilical cord blood hematopoietic stem cell transplantation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@ast
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@en
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@nl
type
label
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@ast
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@en
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@nl
prefLabel
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@ast
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@en
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@nl
P1476
Current status of umbilical cord blood hematopoietic stem cell transplantation.
@en
P304
P356
10.1016/S0301-472X(00)00540-3
P577
2000-11-01T00:00:00Z